BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 29, 2003
View Archived Issues
Amgen, Genentech Legal War Ends With Payout Settlement
Read More
Exploring Brain Neurons In Rats, Fish Rebuts Dogma That Memory Molecules Consolidate Only Once
Read More
As IPO Market Improves, Aderis Tries Again, Now Seeking $75M
Read More
Holiday notice
Read More
Berlex Planning Phase III Study Of Leukine In Crohn's Patients
Read More
Other News To Note
Read More
Corrections
Read More
Myogen Raises $40M Privately, Then Registers For $70M IPO
Falling in step with others in the industry, Myogen Inc. Thursday afternoon said it registered for an initial public offering, estimating it would raise $75 million. (BioWorld Today)
Read More